Amazon.com Inc (NASDAQ: AMZN): Stock That Needs Special Handling

Currently, there are 10.59B common shares owned by the public and among those 9.49B shares have been available to trade.

The company’s stock has a 5-day price change of 9.49% and -19.53% over the past three months. AMZN shares are trading -13.86% year to date (YTD), with the 12-month market performance up to 5.26% higher. It has a 12-month low price of $151.61 and touched a high of $242.52 over the same period. AMZN has an average intraday trading volume of 49.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.16%, -3.84%, and -5.13% respectively.

Institutional ownership of Amazon.com Inc (NASDAQ: AMZN) shares accounts for 64.47% of the company’s 10.59B shares outstanding.

It has a market capitalization of $2005.63B and a beta (3y monthly) value of 1.30. The stock’s trailing 12-month PE ratio is 34.22, while the earnings-per-share (ttm) stands at $5.52. The company has a PEG of 1.83 and a Quick Ratio of 0.87 with the debt-to-equity ratio at 0.52. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.41% over the week and 5.22% over the month.

Earnings per share for the fiscal year are expected to increase by 12.63%, and 19.69% over the next financial year. EPS should shrink at an annualized rate of 18.71% over the next five years, compared to 36.89% over the past 5-year period.

Looking at the support for the AMZN, a number of firms have released research notes about the stock. Telsey Advisory Group stated their Outperform rating for the stock in a research note on April 23, 2025, with the firm’s price target at $275-$235. Jefferies coverage for the Amazon.com Inc (AMZN) stock in a research note released on April 22, 2025 offered a Buy rating with a price target of $240. Raymond James was of a view on April 21, 2025 that the stock is Outperform, while Cantor Fitzgerald gave the stock Overweight rating on April 16, 2025, issuing a price target of $270- $230. Morgan Stanley on their part issued Overweight rating on April 14, 2025.

Most Popular

Related Posts